Axa
MGNX icon

Axa’s MacroGenics MGNX Stock Holding History

Axa’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-135,150
Closed -$723K – 1122
2023
Q2 		$723K Hold
135,150
– – ﹤0.01% 893
2023
Q1 		$969K Hold
135,150
– – ﹤0.01% 872
2022
Q4 		$907K Hold
135,150
– – ﹤0.01% 903
2022
Q3 		$468K Hold
135,150
– – ﹤0.01% 974
2022
Q2 		$399K Sell
135,150
-54,250
-29% -$285K ﹤0.01% 998
2022
Q1 		$1.67M Buy
189,400
+174,200
+1,146% +$1.92M ﹤0.01% 866
2021
Q4 		$244K Sell
15,200
-71,700
-83% -$1.35M ﹤0.01% 1104
2021
Q3 		$1.82M Sell
86,900
-15,700
-15% -$378K 0.01% 876
2021
Q2 		$2.76M Sell
102,600
-68,800
-40% -$2.01M 0.01% 827
2021
Q1 		$5.46M Buy
171,400
+150,400
+716% +$3.65M 0.02% 687
2020
Q4 		$480K Buy
+21,000
New +$483K ﹤0.01% 1075
2020
Q3 		– Sell
-32,200
Closed -$899K – 1325
2020
Q2 		$899K Sell
32,200
-143,800
-82% -$2.5M ﹤0.01% 973
2020
Q1 		$1.02M Hold
176,000
– – 0.01% 849
2019
Q4 		$1.92M Hold
176,000
– – 0.01% 805
2019
Q3 		$2.25M Sell
176,000
-2,400
-1% -$34.6K 0.01% 840
2019
Q2 		$3.03M Buy
178,400
+110,026
+161% +$1.89M 0.01% 783
2019
Q1 		$1.23M Hold
68,374
– – ﹤0.01% 934
2018
Q4 		$868K Sell
68,374
-6,700
-9% -$112K ﹤0.01% 990
2018
Q3 		$1.61M Buy
75,074
+55,874
+291% +$1.19M 0.01% 925
2018
Q2 		$396K Buy
+19,200
New +$432K ﹤0.01% 1178
2017
Q4 		– Sell
-14,200
Closed -$262K – 1378
2017
Q3 		$262K Buy
+14,200
New +$246K ﹤0.01% 1229
2015
Q3 		– Sell
-7,300
Closed -$277K – 1484
2015
Q2 		$277K Buy
+7,300
New +$240K ﹤0.01% 1181

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axa's MGNX Position: Q3 2023 in Review

Axa sold out of MacroGenics (MGNX) in Q3 2023, closing a stake of 135,150 shares — an estimated $723K sold.

Axa first reported a position in MGNX in Q2 2015 and held it in 22 quarters. The position peaked at $5.46M in Q1 2021. 127 funds tracked by Wall St. Rank hold MGNX as of Q3 2023.

  • Axa reported no remaining MacroGenics position as of Q3 2023 after selling out during the quarter.
  • Axa sold 135,150 MacroGenics shares in Q3 2023, an estimated $723K.
  • Axa first reported a position in MacroGenics in Q2 2015 and held it in 22 quarters.
  • Axa's MacroGenics position peaked at $5.46M in Q1 2021.
  • 127 funds tracked by Wall St. Rank held MacroGenics as of Q3 2023.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.